Uppsala University Hospital
- Country
- 🇸🇪Sweden
- Ownership
- Subsidiary
- Established
- 1708-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- https://www.akademiska.se
Clinical Trials
69
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (53 trials with phase data)• Click on a phase to view related trials
Oxygen Consumption, Hypoperfusion and Organ Injury After Cardio-pulmonary Bypass
- Conditions
- Cardiac Surgery Requiring Cardiopulmonary Bypass
- First Posted Date
- 2025-04-16
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Uppsala University Hospital
- Target Recruit Count
- 65
- Registration Number
- NCT06930443
- Locations
- 🇸🇪
Uppsala University Hospital, Uppsala, Sweden
Clinical Investigation of Proton Treatment in Hodgkin Lymphoma Patients - PRO-Hodgkin
- Conditions
- Hodgkin Lymphoma
- First Posted Date
- 2025-03-19
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Uppsala University Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT06883604
- Locations
- 🇸🇪
Sahlgrenska University Hospital, Gothenburg, Sweden
🇸🇪Skane University Hospital, Lund, Sweden
🇸🇪Orebro University Hospital, Orebro, Sweden
Study on Orthosis in Cervical Spine Fracture Treatment
- Conditions
- Cervical Spine FracturesCervical Spine InjuryRigid Collar
- First Posted Date
- 2025-02-27
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Uppsala University Hospital
- Target Recruit Count
- 616
- Registration Number
- NCT06848660
Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders
- Conditions
- Eating DisordersAnorexia NervosaAnorexia Nervosa, AtypicalFeeding and Eating Disorders
- First Posted Date
- 2025-01-24
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Uppsala University Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT06792071
- Locations
- 🇸🇪
Uppsala University Hospital, Uppsala, Sweden
A Longitudinal Study of Severe and Enduring Eating Disorders
- Conditions
- Eating DisordersAnorexia NervosaBulimia NervosaBinge Eating DisorderOther Specified Feeding or Eating Disorder
- First Posted Date
- 2024-12-30
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Uppsala University Hospital
- Target Recruit Count
- 800
- Registration Number
- NCT06752304
- Locations
- 🇸🇪
Uppsala University Hospital, Uppsala, Sweden
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next
News
Sana Biotechnology Reports Breakthrough in Type 1 Diabetes Cell Therapy with 6-Month Clinical Data
Sana Biotechnology presented positive 6-month clinical results showing hypoimmune-modified pancreatic islet cells survived and functioned without immunosuppression in type 1 diabetes patients.